ACTIVE-IBD Study: Physical Activity and Sleep in Paediatric Inflammatory Bowel Disease

Sponsor
University Hospital Southampton NHS Foundation Trust (Other)
Overall Status
Recruiting
CT.gov ID
NCT05224193
Collaborator
(none)
50
1
58
0.9

Study Details

Study Description

Brief Summary

Assessment of physical activity on children with Inflammatory Bowel Disease using questionnaires and wrist watch based activity monitors.

The participants will be recruited from paediatric IBD clinics and will undergo questionnaires to assess their activity level, disease activity and quality of life scores. The participants will then be invited to wear a wrist based accelerometer for a week. The participants will complete a physical activity diary, food diary and stool chart at the same time.

Results will be analysed to see the level of physical activity and assess if the participants are meeting the recommended level of physical activity

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    50 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Physical ACTIVity, slEep, Fitness and Quality of Life in Children and Adolescents With Inflammatory Bowel Disease: a 5-year Prospective Observational Cohort Study - The ACTIVE-IBD Study
    Actual Study Start Date :
    Nov 1, 2021
    Anticipated Primary Completion Date :
    Apr 1, 2022
    Anticipated Study Completion Date :
    Sep 1, 2026

    Arms and Interventions

    Arm Intervention/Treatment
    Paediatric Patients with Inflammatory Bowel Disease

    Outcome Measures

    Primary Outcome Measures

    1. Moderate Vigorous Physical Activity measurement [Over 1 Week]

      Amount of time spent performing moderate and vigorous physical activity

    2. Sedentary time [1 week]

      Amount of time spent sedentary

    Secondary Outcome Measures

    1. Disease Activity [At Baseline Clinical Assessment]

      Disease activity scores using either PUCAI (/85) or PCDAI (/100). Higher scores indicate more active disease

    2. Perceived Physical Activity [At Baseline Clinical Assessment]

      Youth Physical Activity Scale - Subjective Assessment of Moderate Vigorous Physical Activity in Hours over a 1 week retrospective period

    3. Amount and Quality of Sleep [At Baseline Clinical Assessment]

      Child Sleep Health Questionnaire scored out of 154 total and is parent/ carer subjective sleep assessment. Scored in four separate domains. Higher scores indicate increased duration and quality of sleep

    4. Nutritional Assessment [At Baseline Clinical Assessment]

      Mid Upper Arm Circumference

    5. Growth Assessment [At Baseline Clinical Assessment]

      Height in meters

    6. Growth Assessment [At Baseline Clinical Assessment]

      Weight in kg

    7. Nutrition Assessment [3 day assessment after baseline visit]

      3 day self-reported food diary

    8. Amount and Quality of Sleep [1 week period]

      Accelerometer measured sleep

    Other Outcome Measures

    1. Quality of Life Score [At baseline clinic assessment]

      Paediatric Quality of Life Score - PEDSQL scored in psychosocial and physical sections. Both are scored out of 100 and the higher the score the better health related quality of life.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    6 Years to 18 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Children/adolescents from age of 6 to 18 years of age

    • Confirmed endoscopic/histology based IBD diagnosis

    • Under the care of the Southampton University Hospitals NHS Foundation Trust paediatric gastroenterology team

    • Able to provide consent / assent to participate in the study

    • Able to understand and/or cooperate with the study requirements

    • Pregnant participants will be included as long as they can complete the physical assessmentsExclusion Criteria:

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Univeristy Hospital Southampton Southampton Hampshire United Kingdom SO16 6YD

    Sponsors and Collaborators

    • University Hospital Southampton NHS Foundation Trust

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital Southampton NHS Foundation Trust
    ClinicalTrials.gov Identifier:
    NCT05224193
    Other Study ID Numbers:
    • RHM CHI1102
    • 301029
    First Posted:
    Feb 4, 2022
    Last Update Posted:
    Mar 10, 2022
    Last Verified:
    Feb 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital Southampton NHS Foundation Trust
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 10, 2022